192 related articles for article (PubMed ID: 27640796)
1. [Elevated serum levels of betatrophin in patients with polycystic ovary syndrome and the influential factors].
Song S; Wang J; Guo C; Jiang T
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Sep; 41(9):969-74. PubMed ID: 27640796
[TBL] [Abstract][Full Text] [Related]
2. Association of betatrophin with metabolic characteristics in overweight/obese and lean women with PCOS.
Li L; Zhang F; Cui J; Shi Y; Xiang J; Wang X; Zhao N; Yan Q; Greenberg AS; Peng Y; Ding X
Gynecol Endocrinol; 2017 Mar; 33(3):238-243. PubMed ID: 27960599
[TBL] [Abstract][Full Text] [Related]
3. Assessment of circulating betatrophin concentrations in lean glucose-tolerant women with polycystic ovary syndrome.
Erol O; Özel MK; Ellidağ HY; Toptaş T; Derbent AU; Yılmaz N
J Obstet Gynaecol; 2017 Jul; 37(5):633-638. PubMed ID: 28319674
[TBL] [Abstract][Full Text] [Related]
4. Serum betatrophin levels are reduced in patients with full-blown polycystic ovary syndrome.
Eksi Haydardedeoglu F; Bagir GS; Haydardedeoglu B; Bozkirli E; Bakiner O; Metin K; Ertorer ME
Gynecol Endocrinol; 2019 Mar; 35(3):224-227. PubMed ID: 30241452
[TBL] [Abstract][Full Text] [Related]
5. Serum betatrophin levels are increased and associated with insulin resistance in patients with polycystic ovary syndrome.
Qu Q; Zhao D; Zhang F; Bao H; Yang Q
J Int Med Res; 2017 Feb; 45(1):193-202. PubMed ID: 28222635
[TBL] [Abstract][Full Text] [Related]
6. Elevated circulating levels of betatrophin are associated with polycystic ovary syndrome.
Calan M; Yilmaz O; Kume T; Unal Kocabas G; Yesil Senses P; Senses YM; Temur M; Gursoy Calan O
Endocrine; 2016 Jul; 53(1):271-9. PubMed ID: 26832343
[TBL] [Abstract][Full Text] [Related]
7. Association of serum betatrophin with fibroblast growth factor-21 in women with polycystic ovary syndrome.
Kahraman S; Altinova AE; Yalcin MM; Gulbahar O; Arslan B; Akturk M; Cakir N; Toruner FB
J Endocrinol Invest; 2018 Sep; 41(9):1069-1074. PubMed ID: 29363048
[TBL] [Abstract][Full Text] [Related]
8. Circulating Angiopoietin-like 8 protein (ANGPTL8/Betatrophin) in patients with polycystic ovary syndrome: a systematic review and multi effect size meta-analysis.
Varikasuvu SR; Panga JR; Satyanarayana MV
Gynecol Endocrinol; 2019 Mar; 35(3):190-197. PubMed ID: 30614305
[TBL] [Abstract][Full Text] [Related]
9. Adipose Insulin Resistance and Circulating Betatrophin Levels in Women with PCOS.
He Y; Hu W; Yang G; Guo H; Liu H; Li L
Biomed Res Int; 2020; 2020():1253164. PubMed ID: 32076603
[TBL] [Abstract][Full Text] [Related]
10. Novel adipokines WISP1 and betatrophin in PCOS: relationship to AMH levels, atherogenic and metabolic profile.
Sahin Ersoy G; Altun Ensari T; Vatansever D; Emirdar V; Cevik O
Gynecol Endocrinol; 2017 Feb; 33(2):119-123. PubMed ID: 27690684
[TBL] [Abstract][Full Text] [Related]
11. Relationship between betatrophin levels and metabolic parameters in patients with polycystic ovary syndrome.
Erbag G; Eroglu M; Turkon H; Sen H; Binnetoglu E; Aylanc N; Asik M
Cell Mol Biol (Noisy-le-grand); 2016 Apr; 62(5):20-4. PubMed ID: 27188865
[TBL] [Abstract][Full Text] [Related]
12. [Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance].
Wan DH; Fan P; Bai H; Song Q; Liu HW
Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):30-4. PubMed ID: 20367923
[TBL] [Abstract][Full Text] [Related]
13. Serum betatrophin levels are significantly increased in obese patients compared to lean patients regardless to the presence of PCOS.
Keyif B; Goksever Celik H; Karamustafaoglu Balci B; Mehves Celebi M; Ozaltin S; Takmaz O; Buyru F; Baştu E
Gynecol Endocrinol; 2020 Aug; 36(8):678-681. PubMed ID: 32129695
[TBL] [Abstract][Full Text] [Related]
14. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.
Durmus U; Duran C; Ecirli S
J Endocrinol Invest; 2017 May; 40(5):487-497. PubMed ID: 27838846
[TBL] [Abstract][Full Text] [Related]
15. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
Pehlivanov B; Mitkov M
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
[TBL] [Abstract][Full Text] [Related]
16. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
[TBL] [Abstract][Full Text] [Related]
17. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
Singh S; Akhtar N; Ahmad J
Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome.
Lankarani M; Valizadeh N; Heshmat R; Peimani M; Sohrabvand F
Gynecol Endocrinol; 2009 Aug; 25(8):504-7. PubMed ID: 19499403
[TBL] [Abstract][Full Text] [Related]
19. Relationship between serum betatrophin levels and the first-phase of glucose-stimulated insulin secretion.
Liu D; Qu H; Wang H; Duan Y; Liu F; Feng Z; Deng H
Obes Res Clin Pract; 2018; 12(Suppl 2):9-15. PubMed ID: 27554132
[TBL] [Abstract][Full Text] [Related]
20. Anti-Mullerian hormone and insulin resistance in classic phenotype lean PCOS.
Caglar GS; Kahyaoglu I; Pabuccu R; Demirtas S; Seker R
Arch Gynecol Obstet; 2013 Oct; 288(4):905-10. PubMed ID: 23553200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
